Last reviewed · How we verify
Edema due to Hepatic Cirrhosis
Approved treatments
- Spironolacton · ACS Biomarker
- Diuril · Salix Pharms
- Frusemide · Melbourne Health
- Torasemide · Medical University of Warsaw
- Microzide · Generic (originally Merck)
Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure. - Aldactone · Generic (originally Searle/Pfizer)
Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure. - Bumex
- Lasix · Generic (originally Hoechst AG)
- spirolactone · Second Xiangya Hospital of Central South University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Edema due to Hepatic Cirrhosis patent landscape — cliff calendar, originator estates, attackable patents
- Edema due to Hepatic Cirrhosis treatment landscape brief
- Edema due to Hepatic Cirrhosis treatment updates RSS
Frequently asked questions about Edema due to Hepatic Cirrhosis
What drugs treat Edema due to Hepatic Cirrhosis?
Tracked treatments include Spironolacton, Diuril, Frusemide, Torasemide, Microzide, Aldactone, Bumex, Lasix.
What is the treatment for Edema due to Hepatic Cirrhosis?
Standard treatment for Edema due to Hepatic Cirrhosis includes Spironolacton, Diuril, Frusemide, Torasemide, Microzide. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Edema due to Hepatic Cirrhosis patent cliff · Edema due to Hepatic Cirrhosis CI report
- Treatment: Spironolacton · ACS Biomarker
- Treatment: Diuril · Salix Pharms
- Treatment: Frusemide · Melbourne Health
- Treatment: Torasemide · Medical University of Warsaw
- Treatment: Microzide · Generic (originally Merck)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing